Atlas Trials

A Phase II Trial to Compare Efficacy and Safety of CRT VS Neo-CRT in Patients Who Achieved CCR for Esophageal Cancer

Clinical trial NCT02959385 · UNKNOWN

Trial details

NCT number
NCT02959385
Sponsor
Tianjin Medical University Cancer Institute and Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Stage II Esophageal CancerStage III Esophageal Cancer
Start date
2016-09-01
Primary completion
2018-09-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.